{"disease":{"id":"candida-vaginitis","name":"candida vaginitis"},"drugs":{"marketed":[{"drug_id":"clotrimazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotrimin","generic_name":"clotrimazole","company_name":"Bayer AG","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"sulfanilamide","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avc","generic_name":"SULFANILAMIDE","company_name":"Pharmobedient","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 13","drug_class":"sulfanilamide","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"gentian-violet","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methylrosaniline Chloride","generic_name":"GENTIAN VIOLET","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"nystatin","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mycostatin","generic_name":"nystatin","company_name":"Generic (originally Squibb)","drug_phase":"marketed","molecular_target":"Ergosterol (fungal cell membrane)","drug_class":"Polyene Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"butoconazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Femstat 3","generic_name":"BUTOCONAZOLE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"","drug_class":"Azole Antifungal","quality_score":34,"revenue":null,"mechanism":""},{"drug_id":"fluconazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diflucan","generic_name":"fluconazole","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"Azole Antifungal [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"omoconazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"OMOCONAZOLE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"omoconazole","quality_score":null,"revenue":null,"mechanism":"Omoconazole works by inhibiting the growth of fungal cells."},{"drug_id":"fluconazol","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluconazol","company_name":"Azienda Sanitaria-Universitaria Integrata di Udine","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Cytochrome P450 2C9, Lanosterol 14-alpha demethylase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"miconazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monistat","generic_name":"miconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Imidazole antifungal","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"fenticonazole","indication_name":"Candidal vulvovaginitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lomexin","generic_name":"FENTICONAZOLE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"fenticonazole","quality_score":null,"revenue":null,"mechanism":"Lomexin works by inhibiting the growth of fungi through interference with the synthesis of ergosterol, a critical component of fungal cell membranes."}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06975436","title":"Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis","phase":"","overall_status":"COMPLETED","enrollment_count":738,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT06056947","title":"Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":577,"lead_sponsor_name":"Ege University","has_results":false},{"nct_id":"NCT03987620","title":"Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":455,"lead_sponsor_name":"Scynexis, Inc.","has_results":true},{"nct_id":"NCT03734991","title":"Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":376,"lead_sponsor_name":"Scynexis, Inc.","has_results":true},{"nct_id":"NCT06835361","title":"Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":264,"lead_sponsor_name":"AVVA Pharmaceuticals Ltd.","has_results":false},{"nct_id":"NCT04219605","title":"Evaluation of a Rapid Microscopic Diagnostic System for Different Vaginitis Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":226,"lead_sponsor_name":"Meir Medical Center","has_results":false},{"nct_id":"NCT03253094","title":"Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Scynexis, Inc.","has_results":true},{"nct_id":"NCT05670535","title":"Sjögren and Gynecologic Considerations","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Ankara City Hospital Bilkent","has_results":false},{"nct_id":"NCT03839875","title":"Evaluation of Efficacy and Safety of Gynomax® XL Ovule","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"Exeltis Turkey","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}